Lifetime risk for cancer death by sex and smoking status: The lifetime risk pooling project

Cancer Causes and Control

Volumn 23, Issue 10, 2012, Pages 1729-1737

  Gawron, Andrew ^a   Hou, Lifang ^a   Ning, Hongyan ^a   Berry, Jarett D ^b   Lloyd Jones, Donald M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cancer; Cancer mortality; Lifetime risk; Sex; Smoking; Tobacco

Indexed keywords

AGE; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; HUMAN; MIDDLE AGED; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; UNITED STATES;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RISK FACTORS; SEX DISTRIBUTION; SMOKING; UNITED STATES;

EID: 84867027959     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9959-0     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Adami HO, Day NE, Trichopoulos D, Willett WC (2001) Primary and secondary prevention in the reduction of cancer morbidity and mortality. Eur J Cancer 37(Suppl 8):S118-S127
3. Sasco AJ, Secretan MB, Straif K (2004) Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45(Suppl 2):S3-S9
4. Doll R, Peto R, Boreham J, Sutherland I (2005) Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426-429
5. Doll R, Hill AB (1964) Mortality in relation to smoking: ten years observations of British doctors. Br Med J 1:1399-1410
6. Doll R, Peto R (1976) Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 2:1525-1536
7. Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309:901-911
8. Jones WJ, Silvestri GA (2010) The Master Settlement Agreement and its impact on tobacco use 10 years later: lessons for physicians about health policy making. Chest 137:692-700
9. Rodu B, Cole P (2002) Impact of the American anti-smoking campaign on lung cancer mortality. Int J Cancer 97:804-806
10. Hopkins DP, Razi S, Leeks KD, Priya Kalra G, Chattopadhyay SK, Soler RE (2010) Smokefree policies to reduce tobacco use. A systematic review. Am J Prev Med 38:S275-S289
11. Chandler MA, Rennard SI (2010) Smoking cessation. Chest 137:428-435
12. Cokkinides V, Bandi P, McMahon C, Jemal A, Glynn T, Ward E (2009) Tobacco control in the United States-recent progress and opportunities. CA Cancer J Clin 59:352-365
13. Roeseler A, Burns D (2010) The quarter that changed the world. Tob Control 19(Suppl 1):i3-i15
14. Leistikow B (2004) Lung cancer rates as an index of tobacco smoke exposures: validation against black male approximate non-lung cancer death rates, 1969-2000. Prev Med 38:511-515
15. Eaton DK, Kann L, Kinchen S et al (2010) Youth risk behavior surveillance-United States, 2009. MMWR Surveill Summ 59: 1-142
16. Merrill RM, Weed DL (2001) Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates. Ann Epidemiol 11:547-553
17. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T (1993) The lifetime risk of developing breast cancer. J Natl Cancer Inst 85:892-897
18. Grunbaum JA, Kann L, Kinchen SA et al (1999) Youth Risk Behavior Surveillance-National Alternative High School Youth Risk Behavior Survey, United States, 1998. MMWR CDC Sur-veill Summ 48:1-44
19. Lloyd-Jones DM (2010) Cardiovascular risk prediction: basic concepts, current status, and future directions. Circulation 121: 1768-1777
20. Lloyd-Jones DM, Dyer AR, Wang R, Daviglus ML, Greenland P (2007) Risk factor burden in middle age and lifetime risks for cardiovascular and non-cardiovascular death (Chicago Heart Association Detection Project in Industry). Am J Cardiol 99: 535-540
21. Lloyd-Jones DM, Larson MG, Leip EP et al (2002) Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:3068-3072
22. Lloyd-Jones DM, Leip EP, Larson MG et al (2006) Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113:791-798
23. Lloyd-Jones DM, Wang TJ, Leip EP et al (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042-1046
24. Lloyd-Jones DM, Wilson PW, Larson MG et al (2003) Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med 163:1966-1972
25. Marma AK, Berry JD, Ning H, Persell SD, Lloyd-Jones DM (2010) Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes 3:8-14
26. Persell SD, Zei C, Cameron KA, Zielinski M, Lloyd-Jones DM (2010) Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey. Arch Intern Med 170:470-477
27. Miller BA, Scoppa SM, Feuer EJ (2006) Racial/ethnic patterns in lifetime and age-conditional risk estimates for selected cancers. Cancer 106:670-682
28. Kim HL, Puymon MR, Qin M, Guru K, Mohler JL (2010) A method for using life tables to estimate lifetime risk for prostate cancer death. J Natl Compr Canc Netw 8:148-154
29. Woloshin S, Schwartz LM, Welch HG (2008) The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 100:845-853
30. Altekruse S, Kosary C, Krapcho M et al (2010) SEER Cancer Statistics Review, 1975-2007 based on November 2009 SEER data submission, posted to the SEER web site, 2010. National Cancer Institute, Bethesda, MD
31. Berry J, Dyer A, Cai X et al (2012) Lifetime risks of Cardiovascular disease. N Engl J Med 366:321-329
32. Lloyd-Jones DM, Martin DO, Larson MG, Levy D (1998) Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129:1020-1026
33. Vasan RS, Beiser A, Seshadri S et al (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 287:1003-1010
34. Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
35. Gaynor J, Feuer E, Tan C et al (1993) On the use of cause-specific failure and conditional failure probabilities. J Am Stat Assoc 88:400-409
36. Merrill RM, Kessler LG, Udler JM, Rasband GC, Feuer EJ (1999) Comparison of risk estimates for selected diseases and causes of death. Prev Med 28:179-193
37. Vollset SE, Tverdal A, Gjessing HK (2006) Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 144:381-389
38. Kurz-Milcke E, Gigerenzer G, Martignon L (2008) Transparency in risk communication: graphical and analog tools. Ann N Y Acad Sci 1128:18-28
39. Sach TH, Whynes DK (2009) Men and women: beliefs about cancer and about screening. BMC Public Health 9:431
40. Timmermans DR, Ockhuysen-Vermey CF, Henneman L (2008) Presenting health risk information in different formats: the effect on participants' cognitive and emotional evaluation and decisions. Patient Educ Couns 73:443-447
41. Marma AK, Lloyd-Jones DM (2009) Systematic examination of the updated Framingham heart study general cardiovascular risk profile. Circulation 120:384-390
42. Gail MH, Brinton LA, Byar DP et al (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886
43. Gail MH, Costantino JP, Bryant J et al (1999) Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J Natl Cancer Inst 91:1829-1846
44. Schonfeld SJ, Pee D, Greenlee RT et al (2010) Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol 28:2411-2417
45. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18:581-592
46. Thun M, Jemal A, Desantis C, Blackard B, Ward E (2009) An overview of the cancer burden for primary care physicians. Prim Care 36:439-454
47. Taylor DH Jr, Hasselblad V, Henley SJ, Thun MJ, Sloan FA (2002) Benefits of smoking cessation for longevity. Am J Public Health 92:990-996
48. Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA (2008) Smoking and smoking cessation in relation to mortality in women. JAMA 299:2037-2047
49. Bosetti C, Gallus S, Peto R et al (2008) Tobacco smoking, smoking cessation, and cumulative risk of upper aerodigestive tract cancers. Am J Epidemiol 167:468-473